TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved April 4, 1980
TCL Archive In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles November 4, 1983
TCL Archive Children’s Oncology Group to Select New Chairman; Four Leaders to Step Aside April 28, 2000
